Gene · 2041
Papers3,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Variation of Nonlinear Refraction and Three-Photon Absorption of Indium-Tin Oxide Quantum Dot Thin Films and Solutions in Near Infrared Range. | Nanomaterials (Basel) | 2023 | 37630903 | PubTator, text mining | PubMed |
| Genetics of Alzheimer's Disease in the African American Population. | J Clin Med | 2023 | 37629231 | PubTator, text mining | PubMed |
| Alzheimer's Disease beyond Calcium Dysregulation: The Complex Interplay between Calmodulin, Calmodulin-Binding Proteins and Amyloid Beta from Disease Onset through Progression. | Curr Issues Mol Biol | 2023 | 37623212 | PubTator, text mining | PubMed |
| SASH1: A Novel Eph Receptor Partner and Insights into SAM-SAM Interactions. | J Mol Biol | 2023 | 37619706 | PubTator, text mining | PubMed |
| Advanced applications of DNA nanostructures dominated by DNA origami in antitumor drug delivery. | Front Mol Biosci | 2023 | 37609372 | PubTator, text mining | PubMed |
| Intervention of next-generation sequencing in diagnosis of Alzheimer's disease: challenges and future prospects. | Dement Neuropsychol | 2023 | 37577182 | PubTator, text mining | PubMed |
| EphrinB2: Expression of a novel potential target in renal cell carcinoma. | Indian J Urol | 2023 | 37575160 | PubTator, text mining | PubMed |
| Transcriptome Analysis of the Inhibitory Effects of 20(S)-Protopanaxadiol on NCI-H1299 Non-Small Cell Lung Cancer Cells. | Molecules | 2023 | 37570716 | PubTator, text mining | PubMed |
| EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets. | Cancers (Basel) | 2023 | 37568780 | PubTator, text mining | PubMed |
| Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer. | Medicine (Baltimore) | 2023 | 37565899 | PubTator, text mining | PubMed |
| Identification of genes critical for inducing ulcerative colitis and exploring their tumorigenic potential in human colorectal carcinoma. | PLoS One | 2023 | 37535606 | PubTator, text mining | PubMed |
| Colorectal cancer-associated mutations impair EphB1 kinase function. | J Biol Chem | 2023 | 37527777 | PubTator, text mining | PubMed |
| Spatially Resolved Proteomic and Transcriptomic Profiling of Anaplastic Lymphoma Kinase-Rearranged Pulmonary Adenocarcinomas Reveals Key Players in Inter- and Intratumoral Heterogeneity. | Int J Mol Sci | 2023 | 37511126 | PubTator, text mining | PubMed |
| Targeting the Cysteine Redox Proteome in Parkinson's Disease: The Role of Glutathione Precursors and Beyond. | Antioxidants (Basel) | 2023 | 37507913 | PubTator, text mining | PubMed |
| Pan-cancer structurome reveals overrepresentation of beta sandwiches and underrepresentation of alpha helical domains. | Sci Rep | 2023 | 37491511 | PubTator, text mining | PubMed |
| Confirmed Synergy Between the ɛ4 Allele of Apolipoprotein E and the Variant K of Butyrylcholinesterase as a Risk Factor for Alzheimer's Disease: A Systematic Review and Meta-Analysis. | J Alzheimers Dis Rep | 2023 | 37483326 | PubTator, text mining | PubMed |
| Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals. | J Alzheimers Dis | 2023 | 37482996 | PubTator, text mining | PubMed |
| Computational Construction of Toxicant Signaling Networks. | Chem Res Toxicol | 2023 | 37471124 | PubTator, text mining | PubMed |
| Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications. | Cancers (Basel) | 2023 | 37444544 | PubTator, text mining | PubMed |
| Cardiovascular Functions of Ena/VASP Proteins: Past, Present and Beyond. | Cells | 2023 | 37443774 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2041/papers?page=10